• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. DUODENOVIDEOSCOPE Back to Search Results
Model Number TJF-150
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Low Blood Pressure/ Hypotension (1914); Pneumonia (2011); Low Oxygen Saturation (2477); Pancreatitis (4481)
Event Date 03/18/2022
Event Type  Injury  
Event Description
Olympus reviewed the following literature titled "technical and clinical success rates of wallflex duodenal stents in unresectable malignant gastric outlet obstruction.A retrospective observational study from a tertiary cancer hospital in india".This study to find the technical and clinical success, and complication rates of duodenal stenting in such patients presented at india¿s largest tertiary care cancer hospital.Technical and clinical success rates were 98.13% and 91.42%, respectively.Complications included bleeding in 12, pancreatitis in 4, and sedation-related complications in 25 of the patients.In the mean follow-up period of 120 days, recurrence of obstructive symptoms was observed in 66 of the patients.Tumor in growth in 59.09%, food impaction in 31.81%, and migration of the stent in 15.15% of patients were reasons for recurrence.The median time between clinical success and recurrence of obstructive symptoms was 148 days (95% confidence interval (ci): 0¿328).Placement of an enteral wallflex stent in patients with malignant goo is a practical, easy, and safe alternative to surgical gastrojejunostomy in malignant goo.Type of adverse events/number of patients: procedure- related bleeding -12 patients.Mild post-procedural pancreatitis - 4 patients.Stent migrations - 10 patients.Mild to moderate pain in the abdomen - 35 patients.Sedation-related complications - 8 patients.Such as hypotension, desaturation, and aspiration pneumonia etc.Death - no reported count.This literature article requires 2 reports.The related patient identifiers are as follows: (b)(6): tjf-150; (b)(6): cf-q160s.This medwatch report is for patient identifier (b)(6).The deaths and abdominal pain were determined to be not reportable.There is no report of any olympus device malfunction in any procedure described in this study.
 
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Event Description
The following additional information was provided by the author: "no we didn't encounter any problem as far as the scope was concerned during these procedures.¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer Contact
masaharu hirose
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8-520
JA   965-8520
426422891
MDR Report Key15106228
MDR Text Key296652752
Report Number9610595-2022-00306
Device Sequence Number1
Product Code FDT
UDI-Device Identifier04953170229459
UDI-Public04953170229459
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K954451
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTJF-150
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/26/2022
Initial Date FDA Received07/26/2022
Supplement Dates Manufacturer Received11/21/2022
Supplement Dates FDA Received12/05/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
NON-OLYMPUS GUIDEWIRE; NON-OLYMPUS STENT
Patient Outcome(s) Other; Required Intervention;
-
-